Search
for
Sort by
Research 301–330 of 1000+
- Androgen receptor gene polymorphism and polycystic ovary syndrome
- Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
- Design and synthesis of novel androgen receptor antagonists with sterically bulky icosahedral carboranes
- Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti‐androgens
- Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial
- Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol
- Use of low-level laser therapy as monotherapy or concomitant therapy for male and female Androgenetic alopecia
- Hypertension and aldosterone levels in women with early-onset androgenetic alopecia
- Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa Roxb.
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Perifollicular Fibrosis: Pathogenetic Role in Androgenetic Alopecia
- Genetic Analysis of Androgen Receptors in Development and Disease
- Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- Evaluation of Sexual Function With an International Index of Erectile Function in Subjects Taking Finasteride for Androgenetic Alopecia
- Autologous activated platelet-rich plasma (AA-PRP) and non-activated (A-PRP) in hair growth: a retrospective, blinded, randomized evaluation in androgenetic alopecia
- Finasteride 5 mg/day treatment of patterned hair loss in normo-androgenetic postmenopausal women
- Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up
- Topical minoxidil in early androgenetic alopecia
- Ornithine decarboxylase is upregulated by the androgen receptor in skeletal muscle and regulates myoblast proliferation
- Hormonal status of male reproductive system: androgens and estrogens in the testis and epididymis. In vivo and in vitro approaches.
- A Review of Androgen‐Progestin Regimens for Male Contraception
- A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia
- An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia
- Clinical utility and validity of minoxidil response testing in androgenetic alopecia
- Personality Disorders and Psychopathologic Symptoms in Patients With Androgenetic Alopecia
- TREATMENT OF FEMALE ANDROGENETIC ALOPECIA WITH MINOXIDIL 2%
- Testosterone metabolism in the skin. A review of its function in androgenetic alopecia, acne vulgaris, and idiopathic hirsutism including recent studies with antiandrogens
- A Mouse Model of Androgenetic Alopecia
- Recent positive selection of a human androgen receptor/ectodysplasin A2 receptor haplotype and its relationship to male pattern baldness